Pancreatic cancer researchers uncover worrying results in mice suggesting that hydroxychloroquine might be fatally toxic for people taking metformin for…More
“This is the moment to not be going to the grocery store, not going to the pharmacy, but doing everything…More
For drugmakers with production in China, the manufacturing problems created by the COVID-19 outbreak are only part of the difficulty.…More
When the year started, many pharma and political experts believed the industry would face intense pricing scrutiny throughout the year, and possibly reforms. But…More
Amid Amgen’s pricing war with Sanofi and Regeneron’s Praluent, PCSK9 cholesterol fighter Repatha has been looking for a leg up in a wide-ranging clinical…More
In an unusual display of coordinated frankness for the industry, a coalition representing generic drug makers, insurers, pharmacies and benefit…More
The specter of global drug shortages looms large amid the coronavirus pandemic. But so far, the supply chain is holding…More
Bristol-Myers Squibb (BMY) management last Friday called a meeting with Wall Street analysts in what one described as a “semi-urgent…More
When a new safety issue arises with a medicine, regulators typically publicize advisories so that not just physicians, but also…More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you…More
